October 24, 2020

The Niche

Knoepfler lab stem cell blog

adipose stem cells

4 min read

With a new document released today the FDA is more clearly on a path to regulate dubious stem cell clinics in the US. Update: in the years since this post, the FDA has more concretely defined autologous adipose stem cells as drug products. There are more than 100 such American clinics that are selling stem cell “treatments” to patients and almost all of them use non-FDA approved stem cell products isolated from fat tissue. The clinics have argued that they do not need FDA …Read More

2 min read

So far in my series of eight simple reasons not to get an unlicensed stem cell treatment I’ve covered three compelling reasons: potential loss of insurance coverage for negative outcomes that could cost hundreds of thousands of dollars, failure of patient follow up by the doctors and clinics, and exclusion from future clinical trial participation. Today in my fourth segment I’m covering something that while very simple, seems to fly under the radar of most patients getting unlicensed stem cell treatments: undesired tissue growth. …Read More